by Madaline Spencer | Jan 1, 2025
by Madaline Spencer | Dec 30, 2024
James Squires, MD, University of Pittsburgh, discusses recent data regarding Bylvay (odevixibat) in patients with progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome. PFIC is a heterogeneous group of autosomal recessive disorders of...
by Madaline Spencer | Dec 27, 2024
Peter Richardson, MD, Executive Vice President and Chief Scientific Officer of Mallinckrodt Pharmaceuticals, discusses recent data regarding Terlivaz (terlipressin) for hepatorenal syndrome (HRS). HRS is a form of renal failure that occurs in patients...
by Madaline Spencer | Dec 23, 2024
Alan Krasner, MD, Chief Medical Officer of Crinetics Pharmaceuticals, discusses the new drug application (NDA) submission of paltusotine for treating acromegaly. Acromegaly is a rare hormonal disorder resulting from the overproduction of growth hormone in the...
by Madaline Spencer | Dec 20, 2024
Carol Roberts, President, The PBCers Organization, discusses the symptom burden of primary biliary cholangitis (PBC). PBC is a chronic, progressive, autoimmune, liver disease in which the bile ducts become inflamed and damaged. This leads to the buildup...
